Involvement of osteopontin upregulation on mesangial cells growth and collagen synthesis induced by intermittent high glucose

Journal of Cellular Biochemistry

Volumn 109, Issue 6, 2010, Pages 1210-1221

  Sun, Jiazhong ^a   Xu, Yancheng ^a   Deng, Haohua ^a   Sun, Suxin ^a   Dai, Zhe ^a   Sun, Yanlei ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cell proliferation; Intermittent high glucose; Mesangial cells; Osteopontin

Indexed keywords

COLLAGEN; GLUCOSE; OSTEOPONTIN; RNA; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; MESANGIUM CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; GLUCOSE; MALE; MESANGIAL CELLS; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 77951741607     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22503     Document Type: Article

References (42)

1. Alain-Pierre G, Campan M, Millet D, Candresse T, Desgranges C. 1993. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 13:120-125. (Pubitemid 23021592)
2. Amemiya T, Sasamura H, Mifune M, Kitamura Y, Hirasashi J, Hayashi M, Saruta T. 1999. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. Kidney Int 56:2055-2063. (Pubitemid 30004734)
3. Asizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA. 1996. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest 98:2218-2227. (Pubitemid 26394194)
4. Brantley JG, Sharma M, Alcalay NI, Heuvel GB. 2003. Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis. Kidney Int 63(4):1240-1248. (Pubitemid 36349989)
5. Buse JB, Hroscikoski M. 1998. The case for a role for postprandial glucose monitoring in diabetes management. J Fam Pract 47:S29-S36. (Pubitemid 128685767)
6. Ceriello A. 1998. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 15:188-193. (Pubitemid 28126152)
7. Cheng SL, Lai C, Fausto A, Chellaiah M, Feng X, McHugh K, Tietelbaum S, Civitelli R, Hruska K, Ross P, Avioli LV. 2000. Regulation of alphaVbeta3 and alpha Vbeta5 integrins by dexamethasone in normal human osteoblastic cells. J Cell Biochem 77:265-276. (Pubitemid 30176655)
8. Cohen MP, Ziyadeh FN. 1994. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45(2):475-484.
9. Diamond JR, Kees-Folts D, Ricardo SD, Pruznak A, Eufemio M. 1995. Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146:1455-1466.
10. Fischer JW, Tschope C, Reinecke A, Giachelli CM, Unger T. 1998. Upregulation of osteopontin expression in renal cortex of strepto- and zotocin-induced diabetic rats is mediated by bradykinin. Diabetes 47:1512-1518. (Pubitemid 28396958)
11. Fumo P, Kuncio GS, Ziyadeh F. 1994. PKC and high glucose stimulate collagen alpha 1 (IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol Renal Fluid Electrolyte Physiol 267:F632-F638. (Pubitemid 2158979)
12. Giachelli CM, Pichler RH, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ. 1994. Osteopontin expression in angiotensin II-induced tubulointers titial nephritis. Kidney Int 45:515-524. (Pubitemid 24065088)
13. Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM. 2003. Fasting plasma glucose variability as a risk factor of retinopathy in type 2 diabetic patients. J Diabetes Complications 17(2):78-81. (Pubitemid 36279504)
14. Harris RD, Steffes MW, Bilous RW, Sutherland DE, Mauer SM. 1991. Global: Glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 40:107-114.
15. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P. 1995. Over-expression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814.
16. Jones SC, Saunders HJ, Qi W, Pollock CA. 1999. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointer-stitial cells. Diabetologia 42:1113-1119. (Pubitemid 29408810)
17. Kaneto H, Morrisey J, McCracken R, Reyes A, Klahr S. 1998. Osteopontin expression in the kidney during unilateral ureteral obstruction. Miner Electrolyte Metab 24:227-237. (Pubitemid 28108259)
18. Kilpatrick ES, Rigby AS, Atkin SL. 2008. A1C variability and the risk of microvascular complications in type 1 diabetes: Data from the Diabetes Control and Complications Trial. Diabetes Care 31(11):2198-2202.
19. Kilpatrick ES, Rigby AS, Atkin SL. 2009. The effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 32:1901-1903.
20. Klahr S, Scheiner G, Ichikawa I. 1988. The progression of renal disease. N Engl J Med 318:1657-1666.
21. Klein R. 1995. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268.
22. Klienman JG, Beshensky A, Worcester EM, Brown D. 1995. Expression of osteopontin, a urinary inhibitor of stonechloromineral crystal growth, in rat kidney. Kidney Int 47:1585-1596.
23. Leehey DJ, Singh AK, Alavi N, Singh R. 2000. Role of angiotensin II in diabetic nephropathy. Kidney Int 58:S93-S98.
24. Li W, Liu X, Yanoff M, Cohen S, Ye X. 1996. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels. Diabetologia 39:537-547.
25. Li JJ, Han M, Wen JK. 2007. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation. Biochem Biophys Res Commun 356:13-19. (Pubitemid 46413122)
26. Lin CL, Wang JY, Huang YT, Kuo YH, Surendran K, Wang FS. 2006. Wnt/bcatenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol 17:2812-2820. (Pubitemid 44484671)
27. Magi AB, Pichler RH, Johnson RJ. 1997. Osteopontin in chronic puromycin amino-nucleoside nephrosis. J Am Soc Nephrol 8:1383-1390.
28. Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Okamoto K, Maeshima Y, Ota Z, Nagai R. 1996. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes 45:488-495. (Pubitemid 26110255)
29. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. 1984. Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155.
30. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. 2006. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681-1687.
31. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ. 1999. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571-580. (Pubitemid 29353155)
32. Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking RR, Wolf G, Helmchen U, Stahl RA. 2001. Monocyte chemoattractant protein-1 and osteopon tin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59:1762-1769. (Pubitemid 32336790)
33. Prols F, Heidgress D, Rupprecht HD, Marx M. 1998. Regulation of osteopontin expression in rat mesangial cells. FEBS Lett 422:15-18. (Pubitemid 28052856)
34. Ruoslahti E, Engvall E. 1997. Perspective series: Cell adhesion in vascular biology-integrins and vascular extracellular matrix assembly. J Clin Invest 99:1149-1152.
35. Sahai A, Mei C, Pattison T, Tannen RL. 1997. Chronic hypoxia induces proliferation of cultured rat mesangial cells: Role of calcium and protein kinase C. Am J Physiol 273:F954-F960. (Pubitemid 127752131)
36. Singleton JR, Smith AG, Russell JW, Feldman EL. 2003. Microvascular complications of impaired glucose tolerance. Diabetes 52:2867-2873. (Pubitemid 37466854)
37. Sodhi CP, Batlle D, Sahai A. 2000. Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: Role of PKC and p38MAP kinase. Kidney Int 58:691-700. (Pubitemid 30620018)
38. Steffes MW, Osterby R, Chavers B, Mauer SM. 1989. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081. (Pubitemid 19250390)
39. Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson BR, Saito Y, Betsholtz C. 2002. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 161:799-805. (Pubitemid 34988366)
40. Takeuchi A, Throckmorton DC, Brogden AP. 1995. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiol 268:F13-F19. (Pubitemid 124005455)
41. Towler DA, Bidder M, Latifi T, Coleman T, Semenkovich CF. 1998. Dietinduced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273: 30427-30443. (Pubitemid 28545516)
42. Yu XQ, Nikolic-Paterson DJ, Mu W, Giachelli CM, Atkins RC, Johnson RJ, Lan HY. 1998. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians 110:50-64. (Pubitemid 28051638)